Cargando…
Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
[Image: see text] In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody–drug conjugates (ADCs), have recently been designed, synthesized, and tested, some even in clinical trials. Controlled delivery can be enhanced by changing...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical
Society
2014
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275162/ https://www.ncbi.nlm.nih.gov/pubmed/25385142 http://dx.doi.org/10.1021/bc500481x |